Controlled manufacturing reproducibly maintains defined genetic diversity across AP-SA02 clinical drug product lots . Oral presentation scheduled for today Monday, Sept. 21, 2026 ...
Nearly a century ago, a single colony of Staphylococcus aureus (S. aureus) helped launch the antibiotic age. In 1928, Alexander Fleming returned to his London lab to find that a stray mold had wiped ...
Researchers have revealed how Staphylococcus aureus bacteria extract iron from hemoglobin—a process crucial to their survival during infections. Using a novel time-resolved X-ray solution scattering ...
A large-scale, quality improvement program developed in collaboration with infection prevention experts at the Johns Hopkins ...
InvestorsHub on MSN
Armata Pharmaceuticals shares rise 8% after FDA grants AP-SA02 breakthrough therapy designation
Armata Pharmaceuticals (AMEX:ARMP) shares rose 8% after the company said the US Food and Drug Administration granted ...
Staphylococcus aureus (S. aureus) is a major cause of skin and soft tissue infections that can sometimes lead to sepsis and toxic shock syndrome. The microbe poses a significant threat to public ...
A new study shows efficacy and safety of oral antibiotic therapy, in the form of pills, for Staphylococcus aureus bloodstream infections. Currently, infusions are the standard treatment. An ...
What makes S. aureus so dangerous? The virulence of S. aureus lies in its ability to adapt to environmental pressures and immune defenses quickly. A central feature of its survival strategy is the ...
A population-based analysis of 20 U.S. counties found that 30-day mortality increased substantially in several bacteremia ...
The most detailed study to date on the mechanisms by which a common type of bacterium, Staphylococcus aureus, adapts to living on the human body could help improve the prevention, diagnosis, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results